Paid Clinical Trials for Non-small Cell Lung Cancer

Login to your account

Reset Password

Please Enter Username or Email

Create a free account

I'm a Participant
I'm an Organization

Showing 1 – 20 of 95 results

Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung Cancer

by CTG

in Non-small Cell Lung Cancer

Other

Connecticut

Deadline:

01/01/2030

Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable NSCLC

by CTG

in Non-small Cell Lung Cancer

Other

Maryland

Deadline:

10/01/2027

Repositioning Immunotherapy in VetArans With Lung Cancer

by CTG

in Non-small Cell Lung Cancer

Other

California

Deadline:

03/31/2030

Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer

by CTG

in Non-small Cell Lung Cancer

Other

Kentucky

Deadline:

11/01/2031

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

by CTG

in Non-small Cell Lung Cancer

Other

Alaska

Deadline:

05/24/2030

A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer

by CTG

in Non-small Cell Lung Cancer

Other

Arizona

Deadline:

12/23/2031

Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer: AIM-HIGH (Adjuvant Intervention in Molecular High Risk Patients)

by CTG

in Non-small Cell Lung Cancer

Other

California

Deadline:

05/15/2027

Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer

by CTG

in Non-small Cell Lung Cancer

Other

Alabama

Deadline:

08/01/2026

QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors

by CTG

in Non-small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Merkel Cell Carcinoma, Small Cell Lung Cancer, Urothelial Carcinoma

Other

Alaska

Deadline:

12/31/2030

Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer

by CTG

in Non-small Cell Lung Cancer, Advanced Pancreatic Adenocarcinoma, Unresectable Pancreatic Cancer, Ductal Adenocarcinoma of the Pancreas

Other

Massachusetts

Deadline:

09/10/2027

ITIL-306 in Advanced Solid Tumors

by CTG

in Epithelial Ovarian Cancer, Non-small Cell Lung Cancer, Renal Cell Carcinoma

Other

Missouri

Deadline:

11/01/2039

Volrustomig Priming Regimens Exploratory Phase II Platform Study

by CTG

in Non-small Cell Lung Cancer

Other

California

Deadline:

07/30/2027

A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)

by CTG

in Non-small Cell Lung Cancer

Other

California

Deadline:

10/31/2026

Dyadic Yoga Program for Patients Undergoing Thoracic Radiotherapy and Their Family Caregivers: The Testing of a Mobile Application Delivery

by CTG

in Non-small Cell Lung Cancer

Other

Texas

Deadline:

12/31/2028

Surgery Versus Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer

by CTG

in Non Small Cell Lung Cancer, Non-small Cell Lung Cancer

Other

Georgia

Deadline:

01/31/2029

A Study to Evaluate Chemotherapy Plus Osimertinib Against Chemotherapy Plus Placebo in Patients With Non-small Cell Lung Cancer (NSCLC)

by CTG

in Non-small Cell Lung Cancer

Other

Maryland

Deadline:

06/02/2026

Phase II Umbrella Study of Novel Anti-cancer Agents in Participants With NSCLC Who Progressed on an Anti-PD-1/PD-L1 Containing Therapy

by CTG

in Non-small Cell Lung Cancer

Other

California

Deadline:

09/11/2026

Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer

by CTG

in Breast Cancer, Ovarian Cancer, Non-small Cell Lung Cancer, Endocrine Tumors, Gastrointestinal/Genitourinary Cancers

Other

Maryland

Deadline:

03/23/2028

Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors

by CTG

in Non-small Cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck, Metastatic Melanoma

Other

California

Deadline:

08/09/2029

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

by CTG

in Non-small Cell Lung Cancer

Other

Arizona

Deadline:

02/01/2028

Load more All clinical trials loaded.